Dr. Peter C. Farrell is an Independent Director at Evolus, Inc., a Chairman at Arcturus Therapeutics Holdings, Inc., a Chairman at Arcturus Therapeutics Ltd., a Member at National Academy of Engineering, a Member at The Order of Australia Association Ltd., a Non-Executive Chairman at ResMed, Inc., a Chairman at Arcturus Therapeutics, Inc., a Chairman at Waveguide Corp. and a Chairman-Innovation & Entrepreneurship at The University of New South Wales. He is on the Board of Directors at Evolus, Inc., The Scripps Research Institute, Everyone Counts, Inc., Mikroscan Technologies, Inc., Protostar, Inc., The Reason Foundation, University of California San Diego and UC San Diego Foundation. Dr. Farrell was previously employed as a President & Trustee by Museum of Contemporary Arts San Diego, a Non-Executive Director by Telesso Technologies Ltd., an Independent Non-Executive Director by Pharmaxis Ltd., an Independent Director by NuVasive, Inc., a Non-Executive Chairman by QRxPharma Ltd., a Chairman-Executive Council by Harvard Medical School, a Managing Director by Baxter Center for Medical Research Pty Ltd., a Vice President-Research & Development by Baxter Healthcare Corp. (Japan), and a Foundation Director by Graduate School of Biomedical Engineering. He also served on the board at California Healthcare Institute, CardioDynamics International Corp. and CONNECT. He received his undergraduate degree from The University of Sydney, a graduate degree from Massachusetts Institute of Technology, a doctorate degree from The University of New South Wales and a doctorate degree from the University of Washington.